Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Ann Arbor, Michigan 48106


Purpose:

The purpose of this study is to evaluate the effect of milnacipran on how the brain processes pain in patients with fibromyalgia and to assess the relationship between this effect and brain activation patterns during functional magnetic resonance imaging.


Criteria:

Inclusion Criteria: - Diagnosis of fibromyalgia defined by 1990 American College of Rheumatology (ACR) criteria - Visual analog pain score between 40 and 90 mm - Right-hand dominance Exclusion Criteria: - Suicidal risk - Substance Abuse - Pulmonary dysfunction - Renal impairment - Active cardiac disease - Autoimmune disease - Uncontrolled narrow-angle glaucoma - Active liver disease - Cancer - Active peptic ulcer disease or a history of inflammatory bowel disease or celiac sprue - Unstable endocrine disease - Prostatic enlargement


NCT ID:

NCT00793520


Primary Contact:

Study Director
Allan Spera
Forest Research Institute, a subsidiary of Forest Laboratories Inc


Backup Contact:

N/A


Location Contact:

Ann Arbor, Michigan 48106
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: October 09, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.